Mohamed Tawfik

机构：Novo Nordisk (Denmark) · ORCID：0000-0003-2382-2077

发表论文 27 篇 · 总被引 89 次 · h-index 4

代表论文

• Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025 · BMC Medicine · 被引 28)
• Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials (2024 · Diabetes Obesity and Metabolism · 被引 18)
• Inflammatory markers in end-stage renal disease patients on haemodialysis (2020 · Journal of Medical Biochemistry · 被引 16)
• Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Behçet’s disease (2019 · The Egyptian Rheumatologist · 被引 9)
• Circulating CXCL16 in type 2 diabetes mellitus Egyptian patients (2020 · Journal of Radiation Research and Applied Sciences · 被引 4)
• Protective role of ferulic acid against the damaging effect induced by electromagnetic waves on rat liver and intestine tissues (2018 · Iranian Journal of radiation research/Iranian journal of radiation research · 被引 4)